Correlation Between Bank of America and PharmChem

Can any of the company-specific risk be diversified away by investing in both Bank of America and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and PharmChem, you can compare the effects of market volatilities on Bank of America and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and PharmChem.

Diversification Opportunities for Bank of America and PharmChem

0.52

Correlation Coefficient

Bank of America  PharmChem

Very weak diversification

The 3 months correlation between Bank and PharmChem is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Bank of America i.e., Bank of America and PharmChem go up and down completely randomly.

Pair Corralation between Bank of America and PharmChem

Considering the 90-day investment horizon Bank of America is expected to under-perform the PharmChem. But the stock apears to be less risky and, when comparing its historical volatility, Bank of America is 1.68 times less risky than PharmChem. The stock trades about -0.02 of its potential returns per unit of risk. The PharmChem is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  306.00  in PharmChem on December 27, 2024 and sell it today you would earn a total of  9.00  from holding PharmChem or generate 2.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Bank of America  vs.  PharmChem

Bank of America

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bank of America has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bank of America is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

PharmChem

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in PharmChem are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical indicators, PharmChem is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Bank of America and PharmChem

The main advantage of trading using opposite Bank of America and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.

The idea behind Bank of America and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.